Global Glass Vaccine Vial Market is valued approximately at USD XXX million in 2019 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2020-2027.. Glass has greater thermal stability, enhanced visibility, extraordinary impermeability, outstanding barrier properties and chemical resistance for sterilization purposes, better regulatory clearance and lower environmental impacts. The glass vaccine vial may be made either by pouring molten glass into a mold or by sectioning and finishing tubular glass. Increasing incidences of infectious diseases circulating around the world, such as HIV, Ebola, hepatitis, and others, are the major factors driving the development of the glass vaccine vial industry. As of March 2016, Ebola virus resulted in nearly 29 thousand outbreaks and over 11.3 thousand deaths, according to the World Health Organization. Although the flu outbreak leads to deaths worldwide between 290 thousand to 650 thousand persons. More than 900 thousand individuals were also hospitalized due to the flu in the US in 2018, as per the Center for Disease Control. In comparison, the last COVID-19 pandemic, which resulted in 111 million cases of positive Corona Virus. The need to protect the public from these circulating diseases generates a greater vaccine requirement that is met in these vials. In addition, the market for glass vaccine vials is propelled by rising vaccine trials and production around the globe to counter the spread of diseases. In addition, due to thermal stability, transparency, sterilization and more, the glass material used for vials is advantageous over other materials, which has a positive impact on the inclination towards glass vaccine vials. However, Stringent regulation policies impedes the growth of the market over the forecast period of 2020-2027.

The regional analysis of global Glass Vaccine Vial market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific is the leading/significant region across the world in terms of market share owing to thepresence of major market players. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the growth of the population and increasing patient pool would create lucrative growth prospects for the Glass Vaccine Vial market across Asia-Pacific region.

Major market player included in this report are:
Schott AG, Origin Ltd
DWK Life Sciences
Nippon Electric Glass
Pacific Vial Manufacturing
Corning
SGD Pharma
Nipro
Richland Glass
Stevanato Group
Four Stars Glass
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Molded Glass Vial
Tubular Glass Vial
By Application:
Preventive Vaccine
Therapeutic Vaccine

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027

Target Audience of the Global Glass Vaccine Vial Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors